AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2019
Nov 7, 2019
32566_dirs_2019-11-07_dcb9db45-3239-4333-85df-d9fcf2372910.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2019-11-07
Reporting Person: HENDERSON JOHN T (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-07 | Common Stock | P | 5250 | $23.4604 | Acquired | 64353 | Direct |
| 2019-11-07 | Common Stock | P | 1750 | $23.4604 | Acquired | 2050 | Indirect |
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2